连续前锯肌平面镇痛对VATS术后恢复质量的影响
这项前瞻性双盲随机安慰剂对照试验纳入173例择期VATS患者,比较连续SAPB输注0.2%罗哌卡因与生理盐水复合多模式镇痛的效果。主要结局POD1的QoR-40评分两组无统计学差异(176 vs 172,p=0.1036),SAPB组在恢复室和POD1的阿片消耗显著降低,但住院时间、疼痛评分和并发症无显著差异。
要点
- 连续SAPB未显著改善VATS术后第1天QoR-40评分
- SAPB可减少恢复室及POD1阿片类药物消耗
- 住院时间、疼痛评分和30天再入院率两组相似
核心结论
- 连续SAPB导管输注未改善VATS术后主要结局QoR-40,次要结局差异应视为探索性。
研究设计与样本
- 前瞻性、双盲、随机、安慰剂对照试验,纳入择期VATS成人患者,连续SAPB输注0.2%罗哌卡因或生理盐水,复合标准化多模式镇痛,分析173例(SAPB组88例,对照组85例)。
主要发现
- POD1 QoR-40中位数SAPB组176(166-184) vs 对照组172(159-183),p=0.1036,差异无统计学意义。
- SAPB组恢复室阿片消耗显著低于对照组(8.0±7.4 vs 10.6±9.3 IV MME,p=0.0388)。
- SAPB组POD1阿片消耗显著低于对照组(12.73±10.75 vs 16.45±12.17 IV MME,p=0.0349)。
- 住院时间SAPB组缩短0.8天但无统计学意义(2.69±1.76 vs 3.50±4.01,p=0.0872)。
- 疼痛评分、并发症和30天再入院率两组相似。
临床怎么用
- 连续SAPB可作为VATS多模式镇痛的一部分以减少围术期阿片消耗,但不应预期其显著改善恢复质量评分。
局限性
- 主要结局未达统计学显著性,次要结局差异为探索性,需更大样本研究确认对患者报告恢复的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Video-assisted thoracoscopic surgery (VATS) offers numerous advantages over open surgery; nevertheless, it remains associated with significant postoperative pain. Multiple regional anesthesia techniques have been explored, and the serratus anterior plane block (SAPB) has emerged as a promising option; however, evidence on the use of continuous SAPB infusion for quality of recovery (QoR-40) remains limited. We hypothesized that continuous SAPB infusion, combined with multimodal analgesia, could improve QoR-40 after VATS. METHODS: In this prospective, double-blind, randomized controlled trial, adults undergoing elective VATS received an infusion of either 0.2% ropivacaine or saline via a SAPB catheter, in addition to standardized multimodal analgesia. The primary outcome was the QoR-40 score on postoperative day (POD) 1. Secondary outcomes included QoR-40 scores on POD 2-4, pain scores, opioid consumption in intravenous morphine milligram equivalents (IV MME), length of hospital stay (LOS), complications, and 30-day readmission. RESULTS: A total of 173 patients were analyzed (SAPB: n=88; control: n=85). Median QoR-40 scores on POD 1 were higher in the SAPB group (176 (166-184) vs 172 (159-183); p=0.1036), and remained higher across POD 2 to 4, although not statistically significant. SAPB significantly reduced opioid consumption in recovery (8.0±7.4 vs 10.6±9.3 IV MME; p=0.0388) and on POD 1 (12.73±10.75 vs 16.45±12.17 IV MME; p=0.0349). LOS was also lower but not statistically significant by 0.8 days (2.69±1.76 vs 3.50±4.01; p=0.0872). Pain scores, complications, and 30-day readmissions were similar between groups. CONCLUSIONS: In this prospective, double-blind, randomized, placebo-controlled trial, continuous SAPB catheter infusion did not improve the primary outcome (QoR-40), and the observed differences in secondary outcomes should be interpreted as exploratory. Larger studies are needed to confirm effects on patient-reported recovery.
引用
- Biswas A, Zidan H, Kolodzey L, et al. Impact of continuous serratus plane analgesia on quality of recovery after video-assisted thoracic surgery: a prospective double-blind, randomized, placebo-controlled trial. Reg Anesth Pain Med. 2026. PMID: 42336494. doi:10.1136/rapm-2026-107618
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。